Mechanisms and Dependence on Electrical Resistance |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
To examine neutrophil transepithelial migration in the basolateral-to-luminal direction, bronchial epithelial cells (16HBE) were grown at an air-medium interface on the lower face of
permeable supports, and resistance across each membrane was
recorded before measuring neutrophil transmigration over 2 h.
Subconfluent monolayers (resistance < 250
) permitted
high spontaneous migration of neutrophils (7.4 ± 1%), which
was further enhanced (29.7 ± 3%) in response to interleukin
(IL)-8 (100 ng/ml). Confluent monolayers (250 to 700
)
showed low spontaneous migration (2 ± 0.5%) but responded markedly to IL-8 (12.4 ± 1.3%). Left in culture, 16HBE resistances continued to increase and were associated with minimal spontaneous migration (< 0.5%) or responses to IL-8. Using cells in the 250 to 700
range, neutrophil migration to IL-8
was dose-dependent and was enhanced when epithelial cells
were incubated with a combination of tumor necrosis factor-
and interferon-
. Neutrophil migration was stimulus-specific
and was reduced by preincubation of epithelial cells with a
F(ab')2 anti-intercellular adhesion molecule (ICAM)-1, or by
preincubation of neutrophils with anti-CD18, anti-CD11a,
anti-CD11b, or anti-CD11c, but not by anti-CD11d, indicating
a role for
2-integrin-ICAM-1 interaction in the migration process.
| |
Introduction |
|---|
|
|
|---|
The influx of neutrophils into the airway is a common feature of several inflammatory diseases, including acute bronchitis, adult respiratory distress syndrome, and chronic obstructive pulmonary disease (1, 2). Increased numbers of neutrophils have also been recovered from the airways of patients with severe asthma, and of subjects undergoing acute asthma exacerbations (3, 4).
To be recovered in bronchoalveolar lavage fluid during
such diseases, neutrophils must have migrated from the
circulation to the airway lumen. To accomplish this, neutrophils must first adhere to, and migrate through, the vascular endothelium into the interstitial tissue in response to
a chemotactic gradient. Cells must then undergo a similar
sequence of events to cross the airway epithelium and enter the airway lumen. In the past decade, many of the
events involved in endothelial adherence and transmigration have been delineated. It is known that the adherence of the endothelium can be increased upon exposure to a
range of stimuli including interleukin (IL)-1, tumor necrosis factor (TNF)-
, and endotoxin (5). In response to a spe-cific chemoattractant gradient, neutrophils initially adhere
weakly to the endothelium in a process referred to as tethering or rolling. This weak adherence is dependent largely
upon the class of adhesion molecules known as selectins
(6). Subsequent firm adhesion of neutrophils to the endothelium occurs and is due primarily to the interaction of
2-integrins on the neutrophil surface with intercellular
adhesion molecule (ICAM)-1 on the endothelium (7). Finally, the neutrophil crawls toward intercellular junctions
between adjacent endothelial cells and migrates through
these junctions in a process that uses a combination of
molecules, including platelet-endothelial adhesion molecule-1 (CD31) and
2-integrins (8).
Although the mechanisms involved in transendothelial migration of neutrophils are well established, much less is known regarding the migration of neutrophils across the epithelial barrier. Presumably, the chemotactic gradient required to induce transepithelial migration must be generated either by other cells already present in the airway lumen, or else by the epithelial cell itself. It is clear that the epithelial cell is a rich source of chemoattractant molecules, including chemokines (9). In particular, IL-8, a chemokine that is a potent chemoattractant for, and activator of, neutrophils, can be produced in large amounts by epithelial cells in response to a variety of stimuli, including proinflammatory cytokines, bacteria, fungi, and respiratory viruses (10). It seems likely that transepithelial migration of neutrophils will show several unique characteristics. Not only does the spectrum of adhesion molecules expressed by epithelial and endothelial cells show marked differences (14, 15), but neutrophils must cross the epithelial barrier in a basolateral-to-luminal direction, in contrast to the apical-to-basolateral direction operative in transendothelial migration.
Many of the initial studies of the mechanisms of neutrophil transepithelial migration used cells grown on top of permeable supports and examined migration in the apical-to-basolateral direction (16). Given the relatively polarized distribution of some epithelial cell adhesion molecules, this may not adequately reflect the in vivo situation (14). Indeed, recent studies, using either a human tumor cell line with epithelial cell characteristics (19), or a type II alveolar carcinoma cell line (20), have demonstrated that neutrophil migration is more efficient in the basolateral-to-luminal direction. In the present study, we sought to develop a model of neutrophil transepithelial migration using a transformed normal human bronchial epithelial cell line (16HBE) grown at an air-liquid interface. This cell line has been shown to be able to form polarized monolayers with intact tight junctions and, when grown at an air-liquid interface, can develop cilia (21). We evaluated whether neutrophil transepithelial migration in this model is dependent upon the electrical resistance of epithelial monolayers. We also examined the selectivity of chemoattractant stimuli in inducing neutrophil transmigration, and the effects of cytokine stimulation of the epithelial monolayer on neutrophil transmigration. The role of selected adhesion molecules in the transmigration process was also examined.
| |
Materials and Methods |
|---|
|
|
|---|
Materials and Reagents
The following materials were purchased: Dulbecco's minimal essential medium (DMEM), L-glutamine, and penicillin/streptomycin/fungizone from Biofluids, Inc. (Rockville, MD); fetal bovine serum (FBS) from GIBCO BRL (Grand Island, NY); piperazine- N,N'-bis(2-ethane sulfonic acid) (Pipes), formyl-methionine-leucine-phenylalanine (FMLP), and Type VII rat-tail collagen from Sigma Chemical Co. (St. Louis, MO); Hanks' balanced salt solution from Collaborative Research (Bedford, MA); Millicell 12 mm (1.13 cm2) polycarbonate membranes with 3-µm pores from Millipore (Bedford, MA); percoll from Pharmacia (Uppsala, Sweden); IL-8 and eotaxin from Peprotech (Rocky Hill, NJ); regulated on activation, normal T cell expressed and secreted (RANTES) from R&D (Minneapolis, MN); platelet-activating factor (PAF)- C16 from Bachem (Torrance, CA); and leukotriene (LT) B4 from Biomol (Plymouth Meeting, PA). Antibody to IL-8 was generated by immunization of rabbits with recombinant human IL-8. For inhibition experiments, a purified immunoglobulin (Ig) G fraction was used. Equal concentrations of preimmune IgG were used as a control.
PAG buffer contained 25 mM Pipes, 100 mM NaCl, 5 mM KCl, 0.1% D-glucose, and 0.003% human serum albumin, pH 7.4. PAGCM was PAG containing 1 mM MgCl2 and 1 mM CaCl2.
Neutrophil Purification
Neutrophils were isolated from ethylenediaminetetraacetic acid- anticoagulated blood from normal volunteers by percoll density gradient centrifugation and hypotonic lysis of erythrocytes. Cell count and viability were assessed using erythrocin B dye exclusion. The viability of neutrophils was always greater than 95%. Neutrophils were then labeled with 51Cr as described previously (5) and suspended in PAGCM at a concentration of 1.25 × 106/ml.
Epithelial Cell Culture
The simian virus 40-transformed, immortalized 16HBE bronchial epithelial cell line (21) was a generous gift of Dr. D. Gruenert (University of California, San Francisco, CA). Cells were routinely cultured to confluence on collagen-coated T-75 flasks (Costar, Cambridge, MA) in 100% humidity and 5% CO2 at 37°C. They were grown in DMEM containing 10% FBS, 2 mM L-glutamine, penicillin (100 U/ml), streptomycin (100 U/ml), and fungizone (250 ng/ml). The cells were used between passages 12 and 35.
For experiments, cells were grown on Millicell inserts (3-µm pore size) in 12-well plates. The inserts were placed inside the wells in the usual manner to create a well within a well. Then 4.5 ml of medium was added to each of the 12 wells. This completely submerged the polycarbonate insert. Using a glass pipette tip, the insert was then inverted, ensuring that no air bubbles were trapped under the insert, and exactly 1.7 ml was removed from each well. Each insert was carefully moved to the center of its well to avoid an overlapping meniscus at the edge of the well. Cells were suspended at 5 × 106 cells/ml and each inverted insert was gently seeded with two sequential aliquots of 50 µl (a total of 0.5 × 106 cells/insert). Plates were placed in an incubator at 37°C and 5% CO2 and cells were grown on the micropore membrane with air above and medium below. Inserts were used for experiments typically at 6 to 8 d, when they were returned to their original orientation for measurement of electrical resistance and for transmigration experiments. A diagrammatic representation of this culture system is shown in Figure 1.
|
Measurement of Resistance
Transepithelial resistance was measured using an EVOM epithelial volt-ohmmeter (World Precision Instruments, Sarasota, FL). Measurements were made after standardizing the resistance in 10- and 100-mM solutions of KCl.
The inserts were removed from the 12-well plates and put into individual wells of 24-well plates, with the cell monolayer now on the lower face of the insert. Medium (0.6 ml) was put into each well outside of the insert, and a further aliquot (0.4 ml) of medium was put into the inner compartment formed by each of the inserts. These volumes created an identical fluid level in the inner and outer wells (and no hydrostatic pressure gradient).
The electrodes (STX-2; World Precision Instruments) had a chopstick design with one tip 2.5 mm longer than the other. This allowed the longer electrode to be inserted into one of the wells of the 24-well plate (outer well) and the shorter electrode inside the millicell insert (the inner well), without touching the epithelial monolayers. The electrodes were then separated by the membrane and the epithelial monolayer.
The relationship between electrical resistance and confluence was examined by light microscopy after staining membranes of differing resistances using a Wright's stain.
Transepithelial Migration Assay
After measurement of transepithelial resistance, the monolayers were removed from medium and inverted onto absorbent paper. They were then gently immersed in PAG to remove any remaining medium. Each monolayer was numbered so that its resistance was documented. Each experimental point (spontaneous and stimulated) was performed in triplicate.
The chemoattractant was made up at the desired concentration in PAGCM. The wells of a 24-well plate had 0.6 ml of chemoattractant solution added. Each insert was filled with 0.4 ml of 51Cr-labeled neutrophil suspension (5 × 105 cells). The fluid levels in the inner and outer compartments were identical, avoiding a hydrostatic gradient. The 24-well plates were then incubated at 37°C.
After the appropriate length of time, cells that had migrated to
the outer well were lysed using 2 M NH4OH. The level of radioactivity from each sample was measured in a
counter, and the percent migration was calculated as follows: (counts per min [cpm] of migrated cells)/(cpm of total cells added to upper well) × 100. Specific migration was defined as: (% migration in presence of stimulus)
(% migration in absence of stimulus).
Cytokine Activation of the Epithelium
We (22) and others (15) have previously shown that incubation of
epithelial cells with the combination of TNF-
and interferon (IFN)-
markedly enhances adhesion molecule expression. For
the current studies, epithelial monolayers were immersed in medium containing TNF-
(10 U/ml) and IFN-
(30 U/ml) for 18 h.
Resistance was measured after this treatment. The human recombinant TNF-
and IFN-
used each had a specific activity
of 1 × 107 U/mg and were obtained from Genzyme Diagnostics
(Cambridge, MA).
Adhesion Molecule Inhibition Studies
The role of adhesion molecules on neutrophils in transepithelial migration was investigated by incubating [51Cr]-labeled neutrophils in a volume of 30 µl of PAGCM (3.5 × 106 cells/ml) with appropriate blocking monoclonal antibodies (mAbs) to selected leukocyte adhesion molecules, or with a class-matched control antibody, at 4°C for 30 min. Antibodies were used at 10 times the concentration that, when incubated with neutrophils, gave a maximal fluorescence signal by flow cytometry. Cells were subsequently diluted with PAGCM to 1.25 × 106 cells/ml and added to the epithelial layers as in previous experiments.
For investigations of the role of ICAM-1 on the epithelium, a
F(ab')2 fragment of a blocking antibody to ICAM-1 was used instead of an intact antibody to avoid interactions with Fc
receptors on the neutrophil surface. Monolayers of 16HBE cells were
placed in the orientation used for transmigration studies and incubated with or without mAb in PAGCM for 30 min at 37°C. Antibody was placed in both the inner and outer wells at volumes of
0.2 and 0.3 ml, respectively, and was aspirated before use of the
monolayers in the transmigration assay. Antibody was used at 10 times the concentration that, when incubated with epithelial cells,
gave a maximal fluorescence signal by flow cytometry.
All mAbs to leukocyte adhesion molecules used in our studies have previously been shown to block leukocyte adhesion to appropriate counterligands, either on endothelial cells or purified proteins immobilized on plates. mAbs against leukocyte integrins used were: H52, an IgG1 antibody to CD18; MHM24, an IgG1 antibody to CD11a; HC2, an IgG1 antibody to CD11b (all obtained from Dr. J. Hildreth, Johns Hopkins University, Baltimore, MD); BU15, and IgG1 antibody to CD11c (Immunotech, Westbrook, ME); and 240I, a recently developed blocking antibody to CD11d that has been shown to block CD11d-mediated binding of eosinophils to immobilized vascular cell adhesion molecule (VCAM)-1 (23). These antibodies were generously provided by Dr. Bruce Bochner (Johns Hopkins University). For incubation with epithelial monolayers, MEM-111, a blocking IgG2a antibody to ICAM-1, and TÜ149, an IgG2a antibody to HLA-1, were purchased from Caltag Laboratories (San Francisco, CA).
Statistics
All data are presented as means ± standard error of the mean. Time- and concentration-dependence of migration was assessed using one-way repeated measures analysis of variance. Student's two-tailed t test was used to calculate the statistical significance of differences between groups.
| |
Results |
|---|
|
|
|---|
The relationship between the resistance of 16HBE monolayers and confluence was studied using light microscopy
of stained membranes of different resistances. Monolayers
with resistances significantly < 250
rarely covered the
whole of the membrane. By contrast, cell cultures with resistances of > 250
completely covered the membrane.
After 6 d, the resistance of monolayers was usually in the
range of 250 to 700
. With further incubation, however, resistances continued to increase, reaching values up to 2,000
. There were no further obvious visual differences when
monolayers of higher resistance were stained and examined.
To examine the relationship between resistance and
transmigration, labeled neutrophils were added to the basolateral sides of monolayers of differing resistances and
the migration of neutrophils in the absence of any chemotactic stimulus, or in the presence of 100 ng/ml of IL-8, in a
2-h period was measured. Data are expressed in two ways.
In the first set of experiments, percent migration to IL-8
was plotted against resistance (Figure 2). As can be seen, an exponential curve was seen demonstrating a negative
relationship between resistance and migration. Spearman
rank correlation analysis indicated that resistance was negatively correlated with percent migration (rho = 0.73, P = 0.0001). In additional experiments, we also compared migration to buffer and to IL-8 in membranes with different
ranges of resistances. As shown in Figure 3, subconfluent membranes (< 250
) permitted high spontaneous migration of neutrophils (7.4 ± 1%), and extremely high migration
of neutrophils in response to IL-8. By contrast, confluent
monolayers (resistance 250 to 700
) permitted low spontaneous migration (2 ± 0.5%) but showed a 6-fold enhancement of neutrophil migration to IL-8 (12.4 ± 1.3%). At levels of resistance above 700
, transmigration was
markedly reduced. Given that it became more difficult to
measure migration accurately using membranes with resistances > 700
, and that such high resistances are not observed in vivo or with cultured monolayers of primary human
epithelial cells, all subsequent experiments were performed
using inserts with resistances between 250 and 700
.
|
|
Neutrophil transmigration to 100 ng/ml of IL-8 occurred in a time-dependent manner (P < 0.05) over a 3-h
period (Figure 4). The greatest rate of migration occurred
within the first 2 h, perhaps reflecting gradual equilibration of the chemotactic gradient. Given that migration at
2 h was approximately 80% of that seen at 3 h, we chose to
use 2 h as our routine incubation time. Migration to IL-8 at
2 h was dose-dependent (Figure 5) over a concentration range from 30 to 300 ng/ml. Moreover, this dose-response
curve was shifted significantly (P < 0.05) to the left when
the epithelial monolayer was preincubated with a combination of TNF-
and IFN-
. Migration to IL-8 was dependent upon the creation of a chemotactic gradient, because
no specific transmigration was observed when IL-8 was
preincubated with a specific blocking antibody (specific migration above buffer control = 5.4 ± 1.6% in the presence of preimmune IgG and
0.3 ± 0.4 in the presence of
anti-IL-8; n = 3). Migration was also inhibited when equal
concentrations of IL-8 were added to both sides of the epithelial monolayers (specific migration above buffer control = 4.6 ± 0.6% with IL-8 only below the monolayer and
0.2 ± 0.4 with IL-8 on both sides of the monolayer, n = 4).
|
|
Transepithelial migration of neutrophils was stimulus-specific. In addition to IL-8, pronounced migration was
observed in response to either LTB4 or FMLP (10
7 M),
whereas PAF (10
7 M) was an ineffective stimulus for neutrophil transmigration. Moreover, no transmigration was
observed with the C-C chemokines eotaxin or RANTES
at a final concentration of 100 ng/ml (Figure 6).
|
Preincubation of the epithelial monolayers with antibody to ICAM-1 reduced transepithelial migration by an
average of 70% (Figure 7a). Although analysis of the raw
data did not indicate statistical significance by t test, this
was due to the variability in baseline migration between the
experiments. In each of three experiments, however, migration was reduced in the presence of anti-ICAM-1 (P < 0.05 for paired comparison of normalized data). Experiments also revealed that transmigration was dependent, at least in part, on neutrophil expression of
2-integrins (Figure 7b). Preincubation of neutrophils with antibody to
CD18, the common
chain of these integrins, reduced
transepithelial migration by approximately 50% (P < 0.05 versus control). To determine which individual
2-integrins may serve as counterligands for adhesion, we examined the effects of antibodies to individual
-chains of these molecules (Figure 8). Blockade of either CD11a or
CD11b inhibited transmigration by approximately 35% in
each case. More modest, but statistically significant (P < 0.05 versus control), inhibition was also noted with antibody to CD11c. By contrast, antibody to CD11d did not
inhibit transepithelial migration of neutrophils.
|
|
| |
Discussion |
|---|
|
|
|---|
The complex mechanisms by which neutrophils exit the circulation to reach sites of inflammation have been extensively studied in recent years. In several disease states, however, neutrophils that have traversed the endothelial barrier subsequently migrate across the epithelium to reach the airway lumen. Initial studies of the mechanisms regulating transepithelial migration used monolayers of various epithelial cell lines grown on permeable supports but monitored neutrophil migration in the nonphysiologic apical-to-basolateral direction (16). More recent studies using epithelial carcinoma cell lines, however, have demonstrated that migration occurs primarily in the physiologic basolateral-to-luminal direction (19, 20). This finding is not unexpected, given that many macromolecules, including some adhesion molecules, are distributed in a polarized fashion to apical versus basolateral epithelial membranes (14, 24).
For our current studies, we used a transformed normal
human bronchial epithelial cell line that forms polarized
monolayers with intact tight junctions to develop a model
to study further the mechanisms of transepithelial migration in the basolateral-to-luminal direction. By seeding
cells on the lower face of culture well inserts that had been
inverted, and feeding at a liquid-air interface until confluence was achieved, the inserts could then be returned to
their proper orientation, allowing neutrophils added to
the wells to migrate in the physiologic direction. Part of our
goal was to be able to develop a system in which a simple
measure of electrical resistance could be used to monitor
the confluence and integrity of monolayers on each individual culture insert for use in migration studies. To accomplish this, we performed initial studies using membranes of
differing resistances using a Wright's stain. We found that
resistances of > 250
were associated with intact monolayers, assessed by staining, and resulted in markedly
lower levels of "spontaneous" neutrophil transmigration compared with monolayers with resistances of < 250
.
We also found a clear inverse relationship between electrical
resistance and migration such that, at very high electrical
resistances, little transmigration occurred. It has previously been suggested that the degree of transepithelial migration was largely independent of the resistance of the
monolayer, but this was based upon a comparison of different cell lines with different inherent resistances (18).
Obviously, migration across different cell lines could also
be affected by other parameters, including differential expression of adhesion molecules. To our knowledge, our current studies provide the first direct analysis of the relationship between resistance and neutrophil transmigration in a
single airway epithelial cell population. Although surgical
specimens of human bronchi show an epithelial resistance
of only 100
/cm2 (25), monolayers of primary bronchial
epithelial cells show a mean resistance of approximately 450
/cm2 (26). It has been suggested that this increased resistance in vitro is caused by geometric changes that lead to a
decrease in the length of tight junctions per unit area of
cell membrane (26). It is unclear why electrical resistances
in the 16HBE cells continue to increase with extra time in
culture, inasmuch as no obvious morphologic changes were
noted by light microscopy, but there is precedent for some
primary human epithelial cell monolayers to attain resistances up to 1,800
/cm2 (26). Given our preliminary transmigration data, we chose to restrict our subsequent studies to
monolayers with resistances between 250 and 700
, a range
centered around the mean resistance for primary human
cell monolayers. Using these guidelines, our current model
provides a simple way to exclude individual inserts in which
cells have not achieved confluence or else have achieved supraphysiologic resistances.
Using this model system, migration of human neutrophils across epithelial monolayers showed both time- and concentration-dependence in response to IL-8. This migration was dependent upon the existence of a chemotactic gradient, because when IL-8 was preincubated with blocking antibody, or when equal concentrations of IL-8 were added to both sides of the membrane, the level of migration observed was not different than that observed to buffer control. It was of interest to note that a mean 4-fold increase in neutrophil transmigration was seen to IL-8 in subconfluent monolayers compared with 6-fold in monolayers within our optimal range. This relatively robust response to IL-8 in subconfluent monolayers was surprising, given that IL-8 gradients should equilibrate more rapidly in such cultures. The response in subconfluent monolayers, however, also showed greater individual variability.
Other known chemoattractants for neutrophils, including FMLP and LTB4, were also potent inducers of neutrophil transepithelial migration, whereas the C-C chemokines eotaxin and RANTES, which are mainly chemotactic for eosinophils, monocytes, and some T cells (27), did not cause neutrophil transmigration. Interestingly, although PAF is known to be a potent activator of neutrophils (28) and provocation with PAF can increase airway neutrophilia (29), this lipid was not a stimulus for neutrophil transepithelial migration in our model. These data are in good agreement, however, with those of Liu and coworkers, who also found PAF to be a poor stimulus for inducing neutrophil transepithelial migration (19).
Cytokines such as TNF-
and IFN-
are found in increased amounts in the airways during inflammatory diseases (30). Both of these cytokines are known to stimulate
epithelial cell responses, including increasing surface expression of ICAM-1 (15, 22). Stimulation of epithelial
monolayers with the combination of these cytokines in our
model system significantly enhanced neutrophil transmigration to IL-8, clearly demonstrating that the epithelial monolayer is an active participant in the transmigration process.
The participation of the epithelial monolayer in neutrophil transmigration is mediated, in part, by the adhesion
molecule ICAM-1, inasmuch as preincubation with a specific blocking antibody to this molecule markedly reduced
transmigration. These observations contrast with those of
Liu and colleagues, who failed to demonstrate any inhibition of migration across a lung carcinoma cell line with epithelial characteristics when the monolayer was preincubated with an antibody to ICAM-1 (19). This may reflect
our use of a normal bronchial epithelial cell population
rather than a carcinoma cell population. It is feasible that
the role of ICAM-1 in cell migration could depend upon
both the stimulus and cell type under study. Thus, while
both cell types express ICAM-1, the membrane distribution (e.g., apical versus basolateral) and role in adhesion may vary. Alternatively, the difference between our observations and those of Liu and colleagues (19) could be explained by different mAbs to ICAM-1, or differences in protocol. Neutrophils could adhere to epithelial cells treated
with normal, intact anti-ICAM-1 via interactions with the
Fc
receptors expressed on their surface. Liu and colleagues
(19) attempted to prevent such interactions by preincubating neutrophils with anti-Fc
RIIIb and anti-Fc
RIIIa, whereas we completely avoided the possibility of such interactions by using an F(ab')2 fragment of anti-ICAM-1.
Our data indicating a role of ICAM-1 in neutrophil transepithelial migration is supported by studies showing that
neutrophil adherence to epithelial cells is at least partially
mediated by ICAM-1 (31, 32), and by the demonstration
that in vivo administration of either antisense oligonucleotides or mAbs to ICAM-1 inhibited neutrophil recruitment to the airways in a murine model of endotoxin-induced
neutrophilia (33).
The neutrophil counterligands for ICAM-1 are members of the
2-integrin family of adhesion molecules. When
neutrophils were preincubated with the antibody against
CD18, the common
-chain of this family of adhesion molecules, transmigration was inhibited by approximately 50%.
Antibodies to the individual
-chains of the
2-integrins
yielded variable results. Marked inhibition of transmigration was seen with antibodies to CD11a and CD11b. Inhibition of transmigration by anti-CD11b is consistent with
the data of Liu and associates (19), but these authors did
not observe inhibition by CD11a. Again, this difference
could be explained by variations in the epithelial cell preparations used. Our data are consistent, however, with studies supporting a role of CD11a in neutrophil adhesion to
epithelial cells (32, 34). Although both CD11a/CD18 (also
called lymphocyte function-associated antigen-1) and
CD11b/CD-18 (also called Mac-1) appear to contribute to
neutrophil transepithelial migration in our model, our data
also provide the first evidence for a role for CD11c/CD18.
We also tested, for the first time, the effect of the recently
discovered
2-integrin CD11d/CD18 on transepithelial migration of neutrophils. This molecule, more commonly referred to as
d
2, is expressed on most types of human leukocytes, including neutrophils, and was originally shown
to bind preferentially to ICAM-3 as a counterligand (35).
More recently,
d
2 has been shown also to be an alternative ligand for VCAM-1 (23). The lack of effect of antibody
to
d
2 in our model system would imply that neither
ICAM-3 nor VCAM-1 plays a role in
2-integrin-dependent neutrophil transepithelial migration.
It is of interest that inhibition produced by anti-ICAM-1
antibodies appears greater in our studies than those produced by antibodies to
2-integrins, which appear to inhibit
about 50% of migration. This may in part be technical, in
that baseline migration (in the absence of antibody) was
lower in the anti-ICAM-1 experiments, and it is often easier to markedly inhibit modest responses compared with
robust responses. We must also consider alternative possibilities, however. These data could be taken to suggest
that there are ICAM-1-dependent, but CD11/CD18-independent, adhesion pathways. Alternatively, CD11/CD18
expression on the surface of neutrophils may be increased
during transmigration in membrane areas that are not accessible to the soluble antibody. Further studies will be
necessary to resolve this issue.
In summary, we have developed a model in which 16HBE
cells can be cultured in a fashion to study transepithelial
migration of leukocytes in the physiologically relevant basolateral-to-luminal direction. The suitability of monolayers
on each insert for experimentation can be easily determined
by measuring electrical resistance. The migration of neutrophils across suitable monolayers is dependent upon the
presence of a chemotactic gradient of a relevant neutrophil chemoattractant and is mediated, in part, by interactions
between ICAM-1 on the epithelial cells and appropriate
2-integrin counterligands on the neutrophil. It must be
noted, however, that antibodies to neither ICAM-1 nor
2-integrins completely prevented neutrophil transmigration,
even though they were used at levels 10-fold higher than
those needed to provide saturation of their respective
ligands (as determined by flow cytometry), indicating that
additional ligands on both cell types must also play a role.
The model system described here should prove useful in
permitting further studies aimed at identifying these additional ligands and at identifying the steps in the migration
process in which specific adhesion molecules play a role.
| |
Footnotes |
|---|
Abbreviations: formyl-methionine-leucine-phenylalanine, FMLP; intercellular adhesion molecule, ICAM; interferon, IFN; immunoglobulin, Ig; interleukin, IL; leukotriene, LT; monoclonal antibody, mAb; platelet-activating factor, PAF; regulated on activation, normal T cell expressed and secreted, RANTES; tumor necrosis factor, TNF; vascular cell adhesion molecule, VCAM.
(Received in original form December 14, 1999 and in revised form May 3, 2000).
Acknowledgments: The authors thank Dr. Bruce Bochner for generously providing antibodies to adhesion molecules and both Dr. Bochner and Dr. Albert Polito for helpful discussions. The authors also thank Stephen Richards for technical assistance. This work was supported by grant number AI37163 from the National Institutes of Health.
| |
References |
|---|
|
|
|---|
1. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141: 471-501 [Medline].
2. Martin, T. R., G. Raghu, R. J. Maunder, and S. C. Springmeyer. 1985. The effects of chronic bronchitis and chronic airflow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 132: 254-260 [Medline].
3. Sur, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. V. Colby, C. E. Reed, L. W. Hunt, and G. J. Gleich. 1993. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148: 713-719 [Medline].
4.
Wenzel, S. E.,
S. J. Szefler,
D. Y. M. Leung,
S. I. Sloan,
M. D. Rex, and
R. J. Martin.
1997.
Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose corticosteroids.
Am. J. Respir. Crit.
Care Med.
156:
737-743
5. Schleimer, R. P., and B. K. Rutledge. 1986. Cultured human vascular endothelial cells acquire adhesiveness for leukocytes following stimulation with interleukin-1, endotoxin, and tumor-promoting phorbol esters. J. Immunol. 136: 649-654 [Abstract].
6. Bevilacqua, M. P., and R. M. Nelson. 1993. Selectins. J. Clin. Invest. 91: 379-387 .
7. Smith, C. W., S. D. Marlin, R. Rothlein, C. Toman, and D. C. Anderson. 1989. Cooperative interactions of LFA-1 and Mac-1 with intracellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83: 2008-2017 .
8.
Muller, W. A.,
S. A. Weigl,
X. Deng, and
D. M. Phillips.
1993.
PECAM-1 is
required for transendothelial migration of leukocytes.
J. Exp. Med.
178:
449-460
9. Proud, D. 1998. Biology of epithelial cells. In Allergy: Principles and Practice, 5th edition. E. J. Middleton, C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., J. W. Yunginger, and W. W. Busse, editors. Mosby, St. Louis. 306-313.
10.
Cromwell, O.,
Q. Hamid,
C. J. Corrigan,
J. Barkans,
Q. Meng,
P. D. Collins, and
A. B. Kay.
1992.
Expression and generation of interleukin-8, IL-6 and
granulocyte-macrophage colony-stimulating factor by bronchial epithelial
cells and enhancement by IL-1
and tumour necrosis factor-
.
Immunology
77:
330-337
[Medline].
11. Massion, P. P., H. Inoue, J. Richman-Eisenstat, D. Grunberger, P. G. Jorens, B. Housset, J.-F. Pittet, J. P. Wiener-Kronish, and J. A. Nadel. 1994. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J. Clin. Invest. 93: 26-32 .
12. Tomee, J. F., A. T. J. Wierenga, P. S. Hiemstra, and H. K. Kaufman. 1997. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J. Infect. Dis. 176: 300-303 [Medline].
13. Subauste, M. C., D. B. Jacoby, S. M. Richards, and D. Proud. 1995. Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 96: 549-557 .
14. Albelda, S. M.. 1991. Endothelial and epithelial cell adhesion molecules. Am. J. Respir. Cell Mol. Biol. 4: 195-203 .
15. Bloeman, P. G. M., M. C. van den Tweel, P. A. J. Henricks, F. Engels, S. S. Wagenaar, A. A. J. J. L. Rutten, and F. P. Nijkamp. 1993. Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 9: 586-593 .
16. Casale, T. B., M. K. Abbas, and E. J. Carolan. 1992. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier. Am. J. Respir. Cell Mol. Biol. 7: 112-117 .
17.
Bittleman, D. B., and
T. B. Casale.
1995.
Interleukin-8 mediates interleukin-1
-induced neutrophil transcellular migration.
Am. J. Respir. Cell
Mol. Biol.
13:
323-329
[Abstract].
18. Carolan, E. J., and T. B. Casale. 1996. Neutrophil transepithelial migration is dependent upon epithelial characteristics. Am. J. Respir. Cell Mol. Biol. 15: 224-231 [Abstract].
19. Liu, L., F. P. J. Mul, R. Lutter, D. Roos, and E. F. Knol. 1996. Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction. Am. J. Respir. Cell Mol. Biol. 15: 771-780 [Abstract].
20.
Carolan, E. J.,
D. A. Mower, and
T. B. Casale.
1997.
Cytokine-induced neutrophil transepithelial migration is dependent upon epithelial orientation.
Am. J. Respir. Cell Mol. Biol.
17:
727-732
21. Cozens, A. L., M. J. Yezzi, K. Kunzelmann, T. Ohrui, K. Eng, W. E. Finkbeiner, J. H. Widdicombe, and D. C. Gruenert. 1994. CFTR expression and ion transport in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10: 38-47 [Abstract].
22. Subauste, M. C., B. S. Bochner, and D. Proud. 1993. Modulation of ICAM-1 expression on a human bronchial epithelial cell line (BEAS-2B) by cytokines. Am. Rev. Respir. Dis. 147: A435 .
23.
Grayson, M. H.,
M. Van der Vieren,
S. A. Sterbinsky,
W. M. Gallatin,
P. A. Hoffman,
D. E. Staunton, and
B. S. Bochner.
1998.
d
2 integrin is expressed on human eosinophils and functions as an alternative ligand for
vascular cell adhesion molecule 1 (VCAM-1).
J. Exp. Med.
188:
2187-2191
24. van Meer, G., and K. Simons. 1988. Lipid polarity and sorting in epithelial cells. J. Cell. Biochem. 36: 51-58 [Medline].
25.
Knowles, M.,
G. Murray,
J. Shallal,
F. Askin,
V. Ranga,
J. Gatzy, and
R. Boucher.
1984.
Bioelectric properties and ion flow across excised human
bronchi.
J. Appl. Physiol.
56:
868-877
26.
Widdicombe, J. H.,
D. L. Coleman,
W. E. Finkbeiner, and
I. K. Tuet.
1985.
Electrical properties of monolayers cultured from cells of human tracheal
mucosa.
J. Appl. Physiol.
58:
1729-1735
27. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15: 675-705 [Medline].
28. Shaw, J. O., N. Pinckard, K. S. Ferrigni, L. M. McManus, and D. J. Hanahan. 1981. Activation of human neutrophils with 1-O-hexdecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphocholine. J. Immunol 127: 1250-1255 [Abstract].
29. Tedeschi, A., G. Palumbo, N. Milazzo, and A. Miadonna. 1994. Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor. J. Allergy Clin. Immunol. 93: 526-533 [Medline].
30. Kelley, J.. 1990. Cytokines of the lung. Am. Rev. Respir. Dis. 141: 765-788 [Medline].
31. Tosi, M. F., J. M. Stark, A. Hamedani, C. W. Smith, D. C. Gruenert, and Y. T. Huang. 1992. Intercellular adhesion molecule-1 (ICAM-1) dependent and ICAM-1-independent adhesive interactions between polymorphonuclear leukocytes and human airway epithelial cells infected with parainfluenza virus type 2. J. Immunol. 149: 3345-3349 [Abstract].
32. Stark, J. M., V. Godding, J. B. Sedgwick, and W. W. Busse. 1996. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. J. Immunol. 156: 4774-4782 [Abstract].
33. Kumasaka, T., W. M. Quinlan, N. A. Doyle, T. P. Condon, J. Sligh, F. Takei, A. L. Beaudet, C. F. Bennett, and C. M. Doerschuk. 1996. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest. 97: 2362-2369 [Medline].
34. DeRose, V., R. A. Robbins, R. M. Snider, J. R. Spurzem, G. M. Thiele, S. I. Rennard, and I. Rubinstein. 1994. Substance P increases neutrophil adhesion to bronchial epithelial cells. J. Immunol. 154: 1339-1346 [Abstract].
35.
Van der Vieren, M.,
H. Letrong,
C. L. Wood,
P. F. Moore,
T. St. John,
D. E. Staunton, and
W. M. Gallatin.
1995.
A novel leukointegrin,
d
2, binds
preferentially to ICAM-3.
Immunity
3:
683-690
[Medline].
This article has been cited by other articles:
![]() |
O. Tabary, H. Corvol, E. Boncoeur, K. Chadelat, C. Fitting, J. M. Cavaillon, A. Clement, and J. Jacquot Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L588 - L596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Woo, J.-H. Lim, and J.-H. Kim VCAM-1 upregulation via PKC{delta}-p38 kinase-linked cascade mediates the TNF-{alpha}-induced leukocyte adhesion and emigration in the lung airway epithelium Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L307 - L316. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Serikov, H. Choi, K. J. Chmiel, R. Wu, and J. H. Widdicombe Activation of Extracellular Regulated Kinases Is Required for the Increase in Airway Epithelial Permeability during Leukocyte Transmigration Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 261 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Serikov, H. Choi, K. Schmiel, C. Skaggs, N.W. Fleming, R. Wu, and J. H. Widdicombe Endotoxin induces leukocyte transmigration and changes in permeability of the airway epithelium via protein-kinase C and extracellular regulated kinase activation Innate Immunity, February 1, 2004; 10(1): 55 - 65. [Abstract] [PDF] |
||||
![]() |
B. Singh, J. W. Pearce, L. N. Gamage, K. Janardhan, and S. Caldwell Depletion of pulmonary intravascular macrophages inhibits acute lung inflammation Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L363 - L372. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Woo, M.-H. Yoo, H.-J. You, S.-H. Cho, Y.-C. Mun, C.-M. Seong, and J.-H. Kim Transepithelial Migration of Neutrophils in Response to Leukotriene B4 Is Mediated by a Reactive Oxygen Species-Extracellular Signal-Regulated Kinase-Linked Cascade J. Immunol., June 15, 2003; 170(12): 6273 - 6279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kidney, T McManus, and P V Coyle Exacerbations of chronic obstructive pulmonary disease Thorax, September 1, 2002; 57(9): 753 - 754. [Full Text] [PDF] |
||||
![]() |
C. B. Coyne, M. K. Vanhook, T. M. Gambling, J. L. Carson, R. C. Boucher, and L. G. Johnson Regulation of Airway Tight Junctions by Proinflammatory Cytokines Mol. Biol. Cell, September 1, 2002; 13(9): 3218 - 3234. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |